EFA
FBT icon

Englebert Financial Advisers’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Englebert Financial Advisers’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$737K Sell
2,975
-24
-0.8% -$5.17K 0.73% 30
2026
Q1 		$602K Buy
+2,999
New +$620K 0.69% 31

Other funds holding FBT

NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
NC
NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HFM
Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return

Englebert Financial Advisers's FBT Position: Q2 2026 in Review

Englebert Financial Advisers reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.8% in Q2 2026, selling an estimated $5.17K and leaving 2,975 shares worth $737K. The position accounts for 0.73% of the portfolio, ranked #30.

Englebert Financial Advisers first reported a position in FBT in Q1 2026 and has held it in 2 quarters since. 143 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Englebert Financial Advisers held 2,975 shares of First Trust NYSE Arca Biotechnology Index Fund worth $737K as of Q2 2026.
  • Englebert Financial Advisers sold 24 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $5.17K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.73% of Englebert Financial Advisers's portfolio in Q2 2026, its #30 holding.
  • Englebert Financial Advisers first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and has held it in 2 quarters since.
  • 143 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Englebert Financial Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.